Search Everything in One Place

Explore the web, images, videos, news, and more – all in one place.

Sports

Eli Drinkwitz is wrong about Big Ten scheduling and the College Football Playoff

Eli Drinkwitz is wrong about Big Ten scheduling and the College Football Playoff
Sep 14, 2024; Columbia, Missouri, USA; Missouri Tigers head coach Eli Drinkwitz on field against the Boston College Eagles prior to a game at Faurot Field at Memorial Stadium. Denny Medley-Imagn Images

Missouri's head coach raised some eyebrows at SEC Media Days, and he was off about a key point.

Missouri’s head coach raised some eyebrows at SEC Media Days, and he was off about a key point.

Missouri head coach Eli Drinkwitz made waves at SEC Media Days on Monday when he claimed the Big Ten’s refusal to schedule Power Four opponents in non-conference play has helped the conference win three consecutive national titles. While Drinkwitz raises a fair point about the Big Ten’s non-conference scheduling practices, his argument completely misses the mark on the issue he’s trying to address.

There is a legitimate gripe about Big Ten teams padding their records with weak non-conference slates to earn College Football Playoff bids over more battle-tested SEC programs. If Drinkwitz wanted to argue that Big Ten teams winning 10 or 11 games with non-competitive resumes has helped them secure playoff spots over deserving SEC squads, he’d have a valid case. That’s a scheduling and selection committee problem worth discussing.

The problem is that Drinkwitz connected easy scheduling to Big Ten success inside the playoff itself. Those are two entirely different conversations.

Big Ten teams have earned their titles on the field

Performance in the College Football Playoff has nothing to do with how a team built its regular-season resume. Once the bracket is set, every team has to prove itself against elite competition. The Big Ten has done exactly that, beating programs like Tennessee, Texas, Notre Dame, Alabama, and Miami on the postseason stage.

One could even argue that an easier regular-season schedule leaves a team less prepared for the gauntlet of playoff competition. We witnessed that with Ohio State this past year with how they performed against Indiana and Miami. If anything, the Big Ten programs were genuinely superior when it mattered most.

The SEC’s playoff record tells the real story

The most glaring hole in Drinkwitz’s argument is one he conveniently ignored. The SEC is 2-7 against non-SEC teams in the College Football Playoff. That record has nothing to do with the Big Ten’s scheduling habits. It has everything to do with SEC teams not performing when the lights were brightest.

I find it hard to believe that blaming another conference’s path to the playoff for your own conference’s failures inside the playoff is anything but a deflection. The SEC’s struggles in those games are self-inflicted, and no amount of finger-pointing at Big Ten non-conference schedules changes that reality.

Drinkwitz’s frustration is understandable. The SEC plays a grueling conference schedule, and watching teams with lighter paths earn the same postseason opportunities is genuinely aggravating. But conflating the selection process with on-field playoff results weakens what could have been a strong argument.

If you’re going to stand at the podium at SEC Media Days and take a shot at another conference, make sure you’re aiming at the right target. Complain about the selection criteria. Advocate for stronger scheduling requirements across the sport. But don’t pretend that scheduling is the reason your conference keeps losing playoff games. The Big Ten earned those titles on the field, and the SEC’s 2-7 record speaks for itself.

This article was originally published on A to Z Sports. Read the full story here: Eli Drinkwitz is wrong about Big Ten scheduling and the College Football Playoff

© 2026 A to Z Sports.

Read full story on A to Z Sports

Related News

More stories you might be interested in.

Factbox-what we know of weight-loss drugs’ pricing, availability as Novo sues Lilly
Reuters·10 hours ago

Factbox-what we know of weight-loss drugs’ pricing, availability as Novo sues Lilly

July 21 (Reuters) - Novo Nordisk accused Eli Lilly of falsely claiming that its weight-loss medicines are more effective, in a U.S. lawsuit, escalating a rivalry between the leaders of the lucrative obesity drug market. The U.S. Centers for Medicare & Medicaid Services this month launched a pilot that initiated broader access to Novo and Lilly's popular GLP-1 drugs as weight-loss treatments at

Top